University of Leicester
Browse
- No file added yet -

Acute Kidney Injury (AKI) in Aortic Intervention: Findings From the Midlands Aortic Renal Injury (MARI) Cohort Study

Download (156.3 kB)
journal contribution
posted on 2020-02-21, 14:50 authored by Athanasios Saratzis, Shivam Joshi, Ruth A Benson, David Bosanquet, Nikesh Dattani, Andrew Batchelder, Owain Fisher, Eva Ioannidou, Matthew J Bown, Christopher H Imray, VERN collaborators
OBJECTIVES:The incidence of acute kidney injury (AKI) after open (OAR) or endovascular (EVAR) aortic repair is unknown. This research assessed the proportion of patients who develop AKI after aortic intervention using validated criteria, and explored AKI risk factors.
METHODS: This was a multicentre national prospective cohort study. Eleven centres recruited patients undergoing EVAR or OAR (September 2017-December 2018). Serum creatinine (SCr) and urine outputs were measured over a minimum of 48 h or throughout the index inpatient stay to define post-operative AKI using the Kidney Disease Improving Global Outcomes (KDIGO) criteria. Renal decline at 30 days was calculated using estimated glomerular filtration rate (eGFR) and the Major Adverse Kidney Events (MAKE) 30 day composite endpoint (consisting of: death, new dialysis, > 25% eGFR decline).
RESULTS: 300 patients (mean age: 71 years, standard deviation [SD] 4 years; 9% females) were included, who underwent: infrarenal endovascular aneurysm repair (EVAR) 139 patients, fenestrated EVAR (fEVAR) 30, branched EVAR (bEVAR) seven, infrarenal open aneurysm repair (OAR) 98, juxtarenal OAR 26. Overall, 24% of patients developed stage 1 AKI (defined at 48 h as per KDIGO), 2.7% stage 2 AKI and 1% needed renal replacement therapy before discharge. AKI proportions per intervention were: infrarenal EVAR 18%; fEVAR 27%; bEVAR 71%; infrarenal OAR 41%; juxtarenal OAR 63%. Older age (odds ratio [OR] 1.44 for EVAR, 1.58 for OAR), lower baseline eGFR (OR 0.88 EVAR, 0.74 OAR), and ischaemic heart disease (OR 4.42 EVAR, 5.80 OAR) were the main predictors of AKI for infrarenal EVAR and OAR. Overall, 24% developed the MAKE30 endpoint. All patients who died (0.6%) or developed a major cardiac event (5.6%) at one year had developed AKI.
CONCLUSION: AKI and short term renal decline after aortic intervention are common. Age, renal function, and cardiovascular disease are the main risk factors. Research should now focus on AKI prevention in this high risk group.

Funding

NIHR Leicester Biomedical Research Centre

History

Citation

European Journal of Vascular and Endovascular Surgery, 2019, https://doi.org/10.1016/j.ejvs.2019.09.508

Author affiliation

NIHR Leicester Biomedical Research Centre and University of Leicester Department of Cardiovascular Sciences, British Heart Foundation (BHF) Cardiovascular Research Centre, Glenfield Hospital

Version

  • AM (Accepted Manuscript)

Published in

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

Publisher

Elsevier BV

issn

1078-5884

eissn

1532-2165

Acceptance date

2019-09-25

Copyright date

2019

Publisher version

https://www.sciencedirect.com/science/article/pii/S1078588419320210?via=ihub#!

Spatial coverage

England

Language

eng

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC